by neville@docmode.com | Dec 1, 2023 | Blog, Heart Failure
Dr. Krunal Tamakuwala MD, DM (Cardiology), Internventional Cardiology, KD, Hospital Ahmedabad The PARAGON-HF trial analyzed the effects of Sacubitril/Valsartan on heart failure patients\ with preserved ejection fraction (HFpEF). The study found that...
by neville@docmode.com | Dec 1, 2023 | Blog, Heart Failure
Dr. Vineet Mallik MBBS, MD (Medicine), DM (Cardiology), The Heart Clinic, Delhi. The PARAGLIDE-HF trial and PARAGON-HF were multicenter, double-blind, randomized, active-controlled trials comparing sacubitril/valsartan vs. valsartan in patients with...
by neville@docmode.com | Dec 1, 2023 | Blog, Heart Failure
Dr. Varun Sibal MBBS (LTMMC), DNB (General Medicine), DNB, (Cardiology), Chief Interventional Cardiologist A study involving 305 patients with heart failure (HF) with reduced ejection fraction found that 49.2% received two current recommended drugs at...
by neville@docmode.com | Nov 30, 2023 | Blog, Heart Failure
Dr. Hitesh Shah M.D. (Med), D.M. (Cardiology), FESC, Interventional Cardiologist, Ex Asst. Professor of Cardiology, Kahan Cardiac Clinic, Ahmedabad. Recommendations are crucial in the rapidly expanding field of heart failure (HF). The American College of...
by neville@docmode.com | Nov 30, 2023 | Blog, Cardiovascular Disease, Heart Failure
Dr. Kanish Bansal MBBS, MD (Internal Medicine), PGDDM (UK), Consultant Physician and Diabetolgist, Chandigarh This review examines the effectiveness and safety of angiotensin receptor-neprilysin inhibitor (ARNI) combined with sodium–glucose cotransporter-2...
